Alliance Pharma PLC Fundamentals Datasheet and Stock Analysis


Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international. The Company's therapeutic areas of focus include cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology and travel health. The Company's product categories include prescription only medicines, over the counter medications, medical devices, cosmetics and nutritional supplements. The Company's products include SkinSafe, Lift Plus, AbsorbaGel, DeoGel, LaVera, ClearWay, Gelclair, ImmuCyst 81mg, Hydromol, MacuShield, Lypsyl, Anbesol Adult Strength Gel, MolluDab and Ashton & Parsons Infants' Powders.

  • Current Price:
  • Industry:
     Health Care
  • Sector:
     Health Care
  • ISIN:
  • Market Sector:
  • Main Indices:
  • Country of register:
     Great Britain
  • Currency:
  • Shares in Issue:
  • Market Cap:
  • Date Listed:
Operation Breakdown
Geographical - by origin (turnover)
Product (turnover)


Activity Data Not Available

Company Information

CEO: Peter Butterfield  CFO: Andrew Franklin  Non-Executive Chairman: David Cook  Independent Non-Executive Director: Jo Le Couilliard, Nigel Clifford Richard Jones  Company Secretary: Rob Bellhouse  

Composite Ranking: 63
Historic EPS Ranking: 21
Forecast EPS Ranking: 
Price Relative Strength: 26
Industry Strength: C
SMR Ranking: B
ROCE Ranking: C
Accumulation/Dist: C
Mkt Accumulation/Dist: C
Unbroken Annual EPS: D
Unbroken Interim EPS: D
PEG Current Ranking: H
PEG Forecast Ranking: H
PE Current Ranking: D
PE Forecast Ranking: D
Margin Current Ranking: C
Margin Forecast Ranking: B
Add Indicator


Takes the average of data over a period of time, and migrates the period across the data series one data point at a time. This formula smooths a data series and makes analysing volatile data easier.
Operating Profit/(loss)£m13.3610.8516.7725.3130.1623.6535.6316.32£m0.00
Profit Before Tax£m12.0110.1615.1822.2228.2922.8031.0813.02£m35.30
Profit After Tax£m9.588.3812.6918.0928.8318.3625.018.03£m0.00
Profit After Tax (from discontinued operations)£m0.£m0.00
Overall Profit for the Period£m9.588.3812.6918.0928.8318.3625.018.03£m0.00
EPS Growth%1.94(14.13)43.99(16.04)57.59(40.20)31.11(67.80)%12.00
Earnings Per Sharep3.683.164.553.826.023.604.721.52p5.34
Op. Cash Flow P/Sp3.544.302.863.575.644.346.757.74£0.00
Cash Flow P/S Grth%742.8621.47(33.49)24.8357.98(23.05)55.5314.67%0.00
Net Cash Flow P/Sp0.£0.00
Capital Exp P/S££0.00
Tax Rate%
P/E Ratiox10.6011.209.4012.3011.0018.2017.3056.80x14.80
P/E Growth££1.20
Turnover Per Share££0.00
Pre-Tax Profit / Share££0.00
Operating Margin%29.5124.9234.6925.9629.6720.0126.2712.57%0.00
Mkt Cap£m209.88187.58233.32252.99358.46357.79443.23467.26£m0.00
Dividend Per Sharep0.911.
DPS Growth%
Dividend Yield%2.202.802.502.602.002.200.601.80%2.10
Dividend Coverx4.213.363.
Shareholder Funds£m64.6770.78162.44179.26203.11252.20274.18280.96£m0.00
Net Borrowings£m(0.69)(1.43)(3.23)(7.22)(11.18)(10.89)(17.83)(28.90)£m0.00
Net Assets£m64.6770.78162.44179.26203.11252.20274.18280.96£m0.00
Net Assets P/S££0.00
Latest Forecast
Div Yield1.7%1.8%
Div Cover3.2%3.3%
Op Margin12.6%22.4%
Director Deals
Traded Action Notifier Price Amount Value
07-May-20Exercise of optionPeter Butterfield4,750.00p200,000,639,500,000
05-Dec-19SellAndrew Franklin76.90p1,371,616,631,054,772.70
02-Dec-19Exercise of optionAndrew Franklin46.75p1,500,000£,701,250
07-Oct-19SellPeter Butterfield73.50p2,791,546,632,051,786.35
07-Oct-19Exercise of optionPeter Butterfield34.50p3,137,546,631,082,453.37
22-Jan-19BuyRichard Jones65.28p15,000,639,792
09-Nov-18SellJohn Dawson70.10p1,100,000£,771,099.97
14-Feb-17SellPeter Butterfield48.75p 61,846£30,149.93
14-Feb-17Exercise of optionPeter Butterfield33.25p 90,222£29,998.82
27-Oct-16Exercise of optionAndrew Franklin47.50p 400,000£190,000
First PagePrev PageNext Page  Rows per page
534m    Major: 35%    Director: 0%
Notifier Holding Value
Peter Butterfield412,461Ɓ,238.58
David Cook234,129Ú,676.49
Nigel Clifford180,663¨,739.24
Andrew Franklin128,384w,910.66
Richard Jones15,000,010
  Rows per page
Gearing & Cover
News Title Date Time Source
Notification of Major Holdings29-May-2017:21RNS
Result of AGM18-May-2014:43RNS
AGM Statement18-May-2007:00RNS
Director?s Dealing11-May-2015:44RNS
Total Voting Rights01-May-2011:47RNS
Annual Report and Notice of AGM22-Apr-2017:00RNS
Block Admission Application08-Apr-2007:00RNS
Full Year Results 201907-Apr-2007:00RNS
Total Voting Rights02-Apr-2015:53RNS
Notification of Preliminary Results & Analyst Call30-Mar-2007:00RNS
First PagePrev PageNext Page  Rows per page
Broker Opinion
Date Broker Name Rec Price Old Price Target New Price Target Broker Change
27-May-15Numis SecuritiesAdd43.75p0.00p48.00pDownGrade
26-Mar-15Canaccord GenuityBuy34.38p37.00p40.00pReiteration
19-Jun-13Investec SecuritiesHold36.38p35.20p35.80pDownGrade
06-Jun-13Nplus1 BrewinHold37.25p37.00p37.00pReiteration
12-Sep-12Peel Hunt LimitedHold25.50p24.00p25.60pReiteration
16-Jan-12Brewin DolphinHold28.75p33.00p31.00pDownGrade
17-Nov-11Collins StewartBuy29.50p0.00p36.00pNew Coverage
  Rows per page

This functionality requires you to login

Click here to login
Or register for a new account